MRNA vs NVAX

    Moderna Inc. and Novavax Inc. on the same 0–100 framework, as of 2026-10-26.

    The short answer

    On the data Autonium publishes, MRNA currently scores 47/100 against NVAX's 14/100 — a 33-point gap, with 2 of four coarse factors disagreeing.

    MRNA47/100

    Moderna Inc.

    Neutral

    $218.01 -7.82%

    • MomentumNeutral
    • Technical trendPositive
    • VolatilityNeutral
    • SentimentNeutral
    NVAX14/100

    Novavax Inc.

    Bearish

    $11.26 -12.17%

    • MomentumNegative
    • Technical trendNegative
    • VolatilityNeutral
    • SentimentNeutral

    See what separates MRNA and NVAX

    The weighted signals behind each score live inside Autonium.

    Open the analyzer

    Each side in full

    Wider context

    Autonium publishes research, not recommendations. Scores, factors and written reads describe historical and current data and are not buy or sell advice. Not financial advice. Market data is refreshed on a schedule and may lag. See our methodology and disclosures.